GRAIL (GRAL) Pretax Margin % : -331.99% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is GRAIL Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. GRAIL's Pre-Tax Income for the three months ended in Dec. 2024 was $-127.0 Mil. GRAIL's Revenue for the three months ended in Dec. 2024 was $38.3 Mil. Therefore, GRAIL's pretax margin for the quarter that ended in Dec. 2024 was -331.99%.

The historical rank and industry rank for GRAIL's Pretax Margin % or its related term are showing as below:

GRAL' s Pretax Margin % Range Over the Past 10 Years
Min: -9795.48 Med: -1721.69 Max: -1619.29
Current: -1722.37

GRAL's Pretax Margin % is ranked worse than
96.26% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: -7.13 vs GRAL: -1722.37

GRAIL Pretax Margin % Historical Data

The historical data trend for GRAIL's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Pretax Margin % Chart

GRAIL Annual Data

Trend

Dec18

Dec19

Dec22

Dec23

Dec24

Pretax Margin %

-9,795.48

-1,619.29

-1,721.69

GRAIL Quarterly Data
	Dec18	Dec19	Jun20	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Pretax Margin %	Get a 7-Day Free Trial							-636.51	-843.25	-5,125.06	-601.73	-331.99

Competitive Comparison of GRAIL's Pretax Margin %

For the Diagnostics & Research subindustry, GRAIL's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GRAIL's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GRAIL's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where GRAIL's Pretax Margin % falls into.

Save Embed

;

Save Embed

;

GRAIL Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

GRAIL's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-2162.361	/	125.595
	=	-1,721.69 %

GRAIL's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-126.994	/	38.252
	=	-331.99 %

GRAIL (NAS:GRAL) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

GRAIL Pretax Margin % Related Terms

Thank you for viewing the detailed overview of GRAIL's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

GRAIL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

NL0:Germany NL0:Germany

Address

1525 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.grail.com

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.